Konica Minolta 2015 Annual Report Download - page 120

(Note 1) For details on impairment losses, please refer to “13 Impairment losses on non-financial assets.”
(Note 2) Business restructuring expenses for the current fiscal year include expenses related to structural reform of sales sites in Europe in the Business
Technologies Business, discontinuation of in-house silver nitrate manufacturing for the Healthcare Business, and improvement of the
production system of optical products for the Industrial Business. Business restructuring expenses for the previous consolidated fiscal year
include expenses related to structural reform of sales sites in Europe and North America for the Business Technologies Business, a review of
the production system for lens units used in mobile phones in the Industrial Business and termination of the Group’s film production in the
Healthcare Business, as well as extra retirement payments to early retirees in line with the implementation of an early retirement incentive
program.
(Note 3) Environmental expenditures primarily comprise expenses related to soil remediation on idle land in North America and Japan.
(Note 4) Loss on disposal of mass-produced trial products is the loss on disposal of mass-produced trial products generated by the Industrial Business
in the process of launching new products.
(Note 5) Loss on sales of shares of subsidiaries and associates is a loss on the transfer of shares in subsidiaries and associates in relation to the
structural reform of sales sites of Europe for the Business Technologies Business.
(Note 6) In the previous fiscal year, the loss on business withdrawal included an impairment loss associated with the withdrawal from the glass
substrates for HDDs business for the Industrial Business, and losses on the disposal of inventories. Also, impairment losses include a loss of
¥11,910 million generated from the withdrawal of the glass substrates for HDDs business.
Millions of yen
Thousands of
U.S. dollars
2015 2014 2015
Impairment losses (Note 1) (Note 6) ············································································································································································ ¥ 5,185 ¥17,487 $ 43,147
Business restructuring improvement expenses (Note 2) ········································································································· 3,857 8,927 32,096
Loss on sales and disposals of property, plant and equipment and intangible assets ·············· 2,333 2,672 19,414
Environmental expenditures (Note 3) ········································································································································································· 1,169 641 9,728
Loss on disposal of mass-produced trial products (Note 4) ····························································································· 1,096 - 9,120
Loss on sales of shares of subsidiaries and associates (Note 5) ·············································································· 1,016 - 8,455
Loss on business withdrawal (Note 6) ····································································································································································· - 4,222 -
Others ·············································································································································································································································································· 4,936 3,855 41,075
Total ····················································································································································································································································································· ¥19,595 ¥37,806 $163,061
Millions of yen
Thousands of
U.S. dollars
2015 2014 2015
Personnel expenses ································································································································································································································ ¥321,111 ¥299,559 $2,672,139
Depreciation and amortization expenses ···························································································································································· ¥ 47,905 ¥ 43,827 $ 398,644
The total amount of research and development expenses included in operating expenses for the current
fiscal year is ¥74,295 million (Previous fiscal year: ¥69,599 million).
Principal components within operating expenses (total of cost of sales, selling, general and administrative expenses and other
expenses) by nature are as follows:
27. Operating expenses by nature
The components of other expenses for the years ended March 31, 2015 and 2014 are as follows:
26. Other expenses
119
KONICA MINOLTA, INC. Annual Report 2015
Foundation for GrowthBusiness StrategiesGrowth StrategyCompany Overview and Characteristics Financial Report